RS Neuromarkers Updates

📅 Kick-off (done)

Kick-off to review our project RS Neuromarkers (June,2, 2025).

📅 Tech development of RS-USP and RS-LVO (ongoing)

We are currently developing the two biomarkers: for RS-USP, the focus is on precise segmentation of hypoperfused areas by improving deconvolution algorithms and establishing sensitivity thresholds and for RS-LVO, the aim is to enhance vascular occlusion detection with high sensitivity for M1 occlusions and for distal segments and ACA/PCA.

📅 Study initiation package (ongoing)

We are organizing a clinical trial to collect real-world data, which will enable us to refine our algorithms and develop our biomarkers. We are currently finalizing our dossier (protocol, consent form, insurance, organization with the hospital, etc).

📅 Communication, dissemination and exploitation plan (ongoing)

We are developing a detailed business plan and a go-to-market approach considering the new value proposition of SYLVER with the developed biomarkers to ensure successful product launch & market penetration.